Vijay Pande
62 statements across 22 episodes · 49 bullish · 6 bearish · 2 people on the record · first statement Jul 15, 2017 by Vijay Pande · said 5 times in 5 episodes since 2019 · across every show →
On the record as a speaker too: Vijay Pande's record, appearances and statements → this page counts the times other people say the name.
Mentions by year
brought up most by Steph Smith (2), Sonal Chokshi (1), Marc Andreessen (1), Ben Horowitz (1)
tap a year for its mentions
2025 1 mention in 1 episode
2024 1 mention in 1 episode
2023 2 mentions in 2 episodes 1 per episode
2019 1 mention in 1 episode
Everything said about Vijay Pande, oldest first
Jul 15, 2017 positive
Pande: Early cooperation with regulators creates competitive barriers to entry
“One of the things that I feel is that people often think regulation is a challenge and in some ways it is, but it's also a huge opportunity. In that if, especially in this new space, you can work with regulators and get there first. You can actually have an op…”
Jul 15, 2017 bullish
Pande: Compute will enable university-developed behavioral therapies to scale
“There are programs for all these behavioral issues, whether it's type two diabetes, or anxiety, or PTSD, and the intriguing thing is these programs work, often using things like cognitive behavioral therapy. The challenge is that they're often sitting in unive…”
Jul 15, 2017 bullish
Pande: Bio-IT return multiples will look like software multiples
“The return multiples in this space I think will look like software multiples because these are software companies. These are companies that have software in their heart, they have high margins, they have all the things we like about software, we de-risk them t…”
Jul 15, 2017 positive
Jan 11, 2018 bullish
Pande: Machine learning will convert biological science risks into predictable engineering problems
“I think what we expect to see is the shift from many areas that used to be areas of science risk through engineering mechanisms and machine learning now become really engineering problems. With that in mind, we can finally understand and tackle the technical d…”
Jan 11, 2018 bullish
Jan 11, 2018 negative
Jan 11, 2018 neutral
Jan 11, 2018 bullish
Jan 11, 2018 positive
Pande: Wearable diagnostics require AI software and datasets, not new hardware
“They've shown that the missing piece is not more hardware, but is software. The missing piece is artificial intelligence and gold standard data sets that can take what the Apple Watch can do, And make high quality predictions.”
Jan 11, 2018
Pande: Biological complexity exceeds the limits of unassisted human understanding
“And when you talk to a biologist, and I think what we're starting to realize is that there's a fundamental conclusion that comes from this, is that biology is so complicated that it's probably beyond what the human being can understand.”
Jan 11, 2018 bullish
Jan 11, 2018 negative
Jan 11, 2018 bullish
Mar 23, 2018 bullish
Mar 23, 2018 positive
Pande: Break moonshot bio goals into engineering milestones instead of screening
“If you break it up into little bits, any little bit isn't so bad. And can be engineered. And you sort of do it step by step by step by step. And I think that's, for me, the inspiration for how to take some big crazy thing like going to the moon, that if you di…”
Mar 23, 2018 positive
Mar 23, 2018 bullish
Pande: Biotech market shifting to value reproducible platforms over individual assets
“That's a good point. Like, ML is a platform, ah, amongst others, and then there's data generating platforms, there's data analysis platforms, and that, that platform, I think, really could be a really interesting shift, and we're seeing more and more companies…”
Mar 23, 2018 positive
Pande: Drug discovery roles will shift from wet-lab chemistry to computational engineering
“I think I think we're already seeing a little bit of that with just the shift to CROs, where there's like not a purely medicinal chemist job, a sort of drug designer job. And medicinal chemists have so much great intuition and experience designing drugs that t…”
Jan 2, 2019 bullish
Pande: Basic machine learning classification holds immense value for drug discovery
“Classification's actually fantastic. If I can say, this is the drug I want to take, or this is the stock I want to invest you know any of those things are really exciting, and so I see, sort of, machine learning being, just classification being exciting”
Jan 2, 2019 bullish
Pande: Low-utility diagnostic tests become valuable when tracked as longitudinal data
“If you think of this test from a one off point of view, it may look less useful. But if you think of it from a longitudinal point of view or longitudinal in the context of many other tests, suddenly now this is actually potentially useful information.”
Jan 2, 2019 bullish
Genetic variation databases will transform drug discovery and optimization
“Moreover, we can now see how building a large bank of human genetics variations will transform our understanding on optimizing of drug discovery and response, both for understanding side effects and toxicity, as well as making better drugs and going after new …”
Jan 2, 2019 positive
Jan 2, 2019 bullish
Pande: Digital therapeutics enable continuous, large-scale randomized clinical trials
“And instead on the digital therapeutic side, you can be running the equivalent RCTs of these randomized clinical trials all the time with super huge N. But that of course then puts the onus on, on, on those having digital therapeutics to make the case.”
Jan 2, 2019 positive
Pande: AI will accelerate doctors long before replacing them
“And I think before we talk about replacing doctors at all, that doesn't make any sense when we could be accelerating them. Exactly. And having them do so much more. And I, I'm pretty sure we'll see that first. Just like you don't think a word processor with a …”
Jan 2, 2019 bullish
Jan 2, 2019 positive
Pande: Digital therapeutics mirror the 1980s adoption curve of protein biologics
“In the eighties with the origin of biotech and protein biologics, we already went through, oh, you know, I know what a drug is. A drug's a small molecule. This protein thing, that's weird. I mean, the protein thing, that'll never be a drug. And you can list al…”
Jan 2, 2019 neutral
Jan 2, 2019 bullish
Pande: Longevity therapeutics will focus on extending healthspan, not lifespan
“We're going to start to see drugs, and some of them are associated with what we see people talking about with longevity, but really it's not about living longer, it's about just pushing back those problems further and further. Such that we have a longer, longe…”
Jan 2, 2019
Jan 2, 2019 bullish
Pande: EDA tools applied to biological circuits will revolutionize biology
“I think what we're going to start to see is the literal engineering of biological circuits inside cells. The ability to design circuits, much like we design electronic circuits. And the reason why this is important is that there's only so much you can do by ha…”
Jan 2, 2019 positive
Jan 2, 2019 positive
Pande: Dual-domain biology and computer science founders will be a major trend
“What we're really seeing emerging are new founders, Founders that also live in both of these worlds. Founders that have deep experience in the biology and deep experience in computer science, and actually, for these types of companies, I think that's going to …”
Jan 2, 2019 bullish
Pande: a16z Bio targets startups with minimal underlying science risk
“We're looking for companies where the science risk has been removed or greatly de-risked. And so that often, ah, sort of removes a lot of traditional type of therapeutic companies. Companies where there's a huge amount of science risk.”
Jan 2, 2019 negative
Jan 2, 2019 negative
Jan 17, 2019 bullish
Jan 17, 2019
Apr 1, 2019 positive
Pande: a16z Bio invests when pure science transitions into engineering
“So, you know, for what we're looking for, especially on the bio side, I'm looking for things where they're right at that cusp between where the science has largely been done, where we're not investing in science projects, and that it's about to scale into engi…”
Nov 21, 2019 neutral
Nov 21, 2019 positive
Pande: AI discovery will give researchers superpowers rather than replacing humans
“The industrialization of discovery is going to take people and give them superpowers that they didn't have before and allow them to scale. And it's going to be this combination of AI machine learning with things like robotic data generation and people driving …”
Nov 21, 2019 positive
Pande: Industrialized processes enable compounding, exponential product improvements
“When you can engineer something, when you can industrialize something, you can make it better, you know, 10% year over year, 20% year over year. And with that type of interest rate, so to speak, Something that starts off kind of crappy kind of ugly, or just ba…”
Jan 6, 2020 positive
Pande: CAR-T cell therapy can melt tumors away within days
“You take T cells out of your body, out of your blood, you re-engineer them to make them sort of supercharged, and you put them back into the patient, and the results of that are just mind-boggling, that tumors can melt away within days, and people are just lit…”
Jan 9, 2023 bullish
Dec 20, 2023 bullish
Jun 28, 2024 positive
Jun 28, 2024 positive
Pande: AI in healthcare should act as care team peer, not just co-pilot
“Where the AI comes in, one idea is a co-pilot, which is like each one of the team members has a co-pilot. But what's interesting about the data is this is like, The AI is a peer, you know, contributor, you know, more of the team and has its role that actually …”
Jun 28, 2024 positive
Pande: AI primary care is viable because general practice relies on triage
“And I think the general practitioner, sort of concierge doctor, that tier is kind of a really interesting tier, because largely you're triaging and sending off to specialists. So the AI doesn't have to be an oncologist and a cardiologist and all these things. …”
Jun 28, 2024 bullish
Pande: Small AI efficiency gains in high-cash-flow clinical trials yield massive impact
“Like, I'm working on, like, something, you know, in drug design or whatever to make big leaps and bounds, and small things for big cash flows can have a huge impact. So something for clinical trials could be huge, or even just picking, like, the order of rank …”
Jun 28, 2024 positive
Pande: Always-on clinical trial infrastructure is impossible without AI
“Yeah, the funny thing about that idea is, I mean, it's a very exciting idea, because we could gain so much knowledge, and we could improve healthcare so much, but like, it's a ridiculous thing to imagine doing, like, without something like AI. Without AI, I do…”
Sep 5, 2024 bullish
Vijay Pande: Compute costs will fall a million-fold over 20 years
“The nice thing about the exponentials is that, you know, things will go down a factor of a thousand, like, every 10 years on the Moore's Law side, and we'll continue to see that. So, a thousand, maybe in 20 years, a million, you know, a thousand times a thousa…”
Sep 5, 2024 bearish
Sep 5, 2024 bullish
Pande: AI adoption in medicine will progress from nursing to specialists
“We're gonna see it gradually, where first it's some bits of nursing, then more of nursing, then some bits of a GP, then maybe some bits of a specialist, and maybe certain specialists like neurology or something like that, where it's about prescribing drugs bas…”
Sep 5, 2024 bullish
Pande: Medicine will transition from a human problem to a data problem
“I think we'll get to that point where medicine will be about incorporating all this data. Data about me as a patient, data about everyone else that's like me to be able to draw the best conclusions. That's something that is just a computer problem. And that mu…”
Sep 5, 2024 bullish
Pande: Healthcare service providers will eventually transition into AI companies
“Well, you can imagine a services company that's providing some sort of healthcare service. It's training AI with its workers. And then the easy things, which are probably the boring things anyways, AI starts to do. And then the more interesting, complicated th…”
Sep 5, 2024 bullish
Oct 3, 2024
Oct 3, 2024 positive
May 30, 2025 bullish
May 30, 2025 positive
Pande: AI-driven behavioral change can tackle the social determinants of mortality
“I think these so-called social determinants of healthcare that are outside of the traditional healthcare system Is actually a large fraction of what leads to mortality and morbidity. And so, AI being able to do behavioral change is such an easy one.”
May 30, 2025 bullish
May 30, 2025 negative
Pande: Current healthcare technology is mostly just digitized user interfaces
“So in terms of technology, I think there is technology in healthcare, but it's largely in a user interface. So like MRI is really the same MRI from like the fifties just now with on a computer display. And so that's not really tech. That's actually, I would ca…”